Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?

Gender Medicine

Volumn 6, Issue PART 2, 2009, Pages 152-167

  Heitkemper, Margaret M ^a   Chang, Lin ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

estrogen; gastrointestinal symptoms; immune; irritable bowel syndrome; menopause; menstrual cycle; pain; pregnancy; progesterone

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE; ESTRADIOL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ARTICLE; DISEASE EXACERBATION; DYSMENORRHEA; EARLY MENOPAUSE; GASTROINTESTINAL SYMPTOM; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; IRRITABLE COLON; MEDLINE; MENOPAUSE; MENSTRUAL CYCLE; NOCICEPTION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SEX DIFFERENCE; VISCERAL PAIN; AGE; ANXIETY; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASE; OVARY; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PERCEPTION; PSYCHOMETRY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDER; WOMEN'S HEALTH;

AGE FACTORS; ANXIETY; DEPRESSION; ESTRADIOL; ESTROGENS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; OVARY; PAIN MEASUREMENT; PERCEPTION; PROGESTERONE; PSYCHOMETRICS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; WOMEN'S HEALTH;

EID: 65249154871     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2009.03.004     Document Type: Article

References (94)

1. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders [published correction appears in Gastroenterology. 2006;131:688]. Gastroenterology 130 (2006) 1480-1491
2. Drossman D.A. What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders?. J Clin Gastroenterol 39 Suppl 3 (2005) S251-S256
3. Hungin A.P., Chang L., Locke G.R., et al. Irritable bowel syndrome in the United States: Prevalence, symptom patterns and impact. Aliment Pharmacol Ther 21 (2005) 1365-1375
4. Müller-Lissner S.A., Bollani S., Brummer R.J., et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 64 (2001) 200-204
5. Taub E., Cuevas J.L., Cook III E.W., et al. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci 40 (1995) 2647-2655
6. Ford A.C., Forman D., Bailey A.G., et al. Irritable bowel syndrome: A 10-yr natural history of symptomsand factors that influence consultation behavior. Am J Gastroenterol 103 (2008) 1229-1239 quiz 1240
7. Kumano H., Kaiya H., Yoshiuchi K., et al. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol 99 (2004) 370-376
8. Hungin A.P., Whorwell P.J., Tack J., and Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40,000 subjects. Aliment Pharmacol Ther 17 (2003) 643-650
9. García Rodríguez L.A., Ruigómez A., Wallander M.A., et al. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 35 (2000) 306-311
10. Talley N.J. Spectrum of chronic dyspepsia in the presence of the irritable bowel syndrome. Scand J Gastroenterol Suppl 182 (1991) 7-10
11. Ouyang A., and Wrzos H.F. Contribution of gender to pathophysiology and clinical presentation of IBS: Should management be different in women?. Am J Gastroenterol 101 Suppl 12 (2006) S602-S609
12. Unruh A.M. Gender variations in clinical pain experience. Pain 65 (1996) 123-167
13. Laessle R.G., Tuschl R.J., Schweiger U., and Pirke K.M. Mood changes and physical complaints during the normal menstrual cycle in healthy young women. Psychoneuroendocrinology 15 (1990) 131-138
14. Heitkemper M.M., Shaver J.F., and Mitchell E.S. Gastrointestinal symptoms and bowel patterns across the menstrual cycle in dysmenorrhea. Nurs Res 37 (1988) 108-113
15. Whitehead W.E., Cheskin L.J., Heller B.R., et al. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology 98 (1990) 1485-1489
16. Heitkemper M.M., and Jarrett M. Pattern of gastrointestinal and somatic symptoms across the menstrual cycle. Gastroenterology 102 (1992) 505-513
17. In: Drossman D., Corazziari E., Thompson W., et al. (Eds). Rome II: The Functional Gastrointestinal Disorders (2000), Degnon Associates, McLean, Va
18. Heitkemper M.M., Cain K.C., Jarrett M.E., et al. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol 98 (2003) 420-430
19. Moore J., Barlow D., Jewell D., and Kennedy S. Do gastrointestinal symptoms vary with the menstrual cycle?. Br J Obstet Gynaecol 105 (1998) 1322-1325
20. Kane S.V., Sable K., and Hanauer S.B. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: A prevalence study. Am J Gastroenterol 93 (1998) 1867-1872
21. Chang L., Lee O.Y., Naliboff B., et al. Sensation of bloating and visible abdominal distention in patients with irritable bowel syndrome. Am J Gastroenterol 96 (2001) 3341-3347
22. Sullivan S.N. A prospective study of unexplained visible abdominal bloating. N Z Med J 107 (1994) 428-430
23. Lee S.Y., Kim J.H., Sung I.K., et al. Irritable bowel syndrome is more common in women regardless of the menstrual phase: A Rome II-based survey. J Korean Med Sci 22 (2007) 851-854
24. Marván M.L., and Cortés-Iniestra S. Women's beliefs about the prevalence of premenstrual syndrome and biases in recall of premenstrual changes. Health Psychol 20 (2001) 276-280
25. Slade P. Premenstrual emotional changes in normal women: Fact or fiction?. J Psychosom Res 28 (1984) 1-7
26. Ross C., Coleman G., and Stojanovska C. Prospectively reported symptom change across the menstrual cycle in users and non-users of oral contraceptives. J Psychosom Obstet Gynaecol 24 (2003) 15-29
27. Truong T.T., Naliboff B.D., and Chang L. Novel techniques to study visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep 10 (2008) 369-378
28. Posserud I., Syrous A., Lindström L., et al. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 133 (2007) 1113-1123
29. Camilleri M., McKinzie S., Busciglio I., et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 6 (2008) 772-781
30. Ragnarsson G., Hallböök O., and Bodemar G. Abdominal symptoms and anorectal function in health and irritable bowel syndrome. Scand J Gastroenterol 36 (2001) 833-842
31. Kim H.S., Rhee P.L., Park J., et al. Gender-related differences in visceral perception in health and irritable bowel syndrome. J Gastroenterol Hepatol 21 (2006) 468-473
32. Chang L., Mayer E.A., Labus J.S., et al. Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome. Am J Physiol Regul Integr Comp Physiol 291 (2006) R277-R284
33. Lembo T., Munakata J., Mertz H., et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome [published correction appears in Gastroenterology. 1997;113:1054]. Gastroenterology 107 (1994) 1686-1696
34. Jackson N.A., Houghton L.A., Whorwell P.J., and Currer B. Does the menstrual cycle affect anorectal physiology?. Dig Dis Sci 39 (1994) 2607-2611
35. Houghton L.A., Lea R., Jackson N., and Whorwell P.J. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 50 (2002) 471-474
36. Stening K., Eriksson O., Wahren L., et al. Pain sensations to the cold pressor test in normally menstruating women: Comparison with men and relation to menstrual phase and serum sex steroid levels. Am J Physiol Regul Integr Comp Physiol 293 (2007) R1711-R1716
37. Fillingim R.B. Sex, gender, and pain: Women and men really are different. Curr Rev Pain 4 (2000) 24-30
38. Giamberardino M.A., Affaitati G., Valente R., et al. Changes in visceral pain reactivity as a function of estrous cycle in female rats with artificial ureteral calculosis. Brain Res 774 (1997) 234-238
39. Bradshaw H.B., Temple J.L., Wood E., and Berkley K.J. Estrous variations in behavioral responses to vaginal and uterine distention in the rat. Pain 82 (1999) 187-197
40. Sanoja R., and Cervero F. Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: A model of functional abdominal pain. Pain 118 (2005) 243-253
41. Bradesi S., Eutamene H., Garcia-Villar R., et al. Stress-induced visceral hypersensitivity in female rats is estrogen-dependent and involves tachykinin NK1 receptors. Pain 102 (2003) 227-234
42. Ji Y., Murphy A.Z., and Traub R.J. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci 23 (2003) 3908-3915
43. Cogan R., and Spinnato J.A. Pain and discomfort thresholds in late pregnancy. Pain 27 (1986) 63-68
44. Strine T.W., Chapman D.P., and Ahluwalia I.B. Menstrual-related problems and psychological distress among women in the United States. J Womens Health (Larchmt) 14 (2005) 316-323
45. Robbins A., Berkley K.J., and Sato Y. Estrous cycle variation of afferent fibers supplying reproductive organs in the female rat. Brain Res 596 (1992) 353-356
46. Talley N.J. Serotoninergic neuroenteric modulators. Lancet 358 (2001) 2061-2068
47. Beglinger C. Tegaserod: A novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome. Int J Clin Pract 56 (2002) 47-51
48. Sumner B.E., Grant K.E., Rosie R., et al. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neurosci Lett 417 (2007) 95-99
49. Houghton L.A., Atkinson W., Whitaker R.P., et al. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 52 (2003) 663-670
50. Houghton L.A., Perry H., Morris J., et al. Plasma 5-hydroxytryptamine concentration varies with gender and menstrual status in irritable bowel syndrome patients with diarrhea (IBS-D) but not healthy volunteers. Gastroenterology 134 Suppl 1 (2008) A681
51. Li T.J., Yu B.P., Dong W.G., et al. Ovarian hormone modulates 5-hydroxytryptamine 3 receptors mRNA expression in rat colon with restraint stress-induced bowel dysfunction. World J Gastroenterol 10 (2004) 2723-2726
52. Mayer E.A., Tillisch K., and Bradesi S. Review article: Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 24 (2006) 919-933
53. Cremonini F., Delgado-Aros S., and Camilleri M. Efficacy of alosetron in irritable bowel syndrome: A metaanalysis of randomized controlled trials. Neurogastroenterol Motil 15 (2003) 79-86
54. Bueno L., de Ponti F., Fried M., et al. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil 19 Suppl 1 (2007) 89-119
55. Koch K.M., Palmer J.L., Noordin N., et al. Sex and age differences in the pharmacokinetics of alosetron. Br J Clin Pharmacol 53 (2002) 238-242
56. Nakai A., Diksic M., Kumakura Y., et al. The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterol Motil 17 (2005) 212-221
57. Gintzler A.R., and Liu N.J. The maternal spinal cord: Biochemical and physiological correlates of steroidactivated antinociceptive processes. Prog Brain Res 133 (2001) 83-97
58. Lu C.L., Hsieh J.C., Tsaur M.L., et al. Estrogen rapidly modulates mustard oil-induced visceral hypersensitivity in conscious female rats: A role of CREB phosphorylation in spinal dorsal horn neurons. Am J Physiol Gastrointest Liver Physiol 292 (2007) G438-G446
59. Smith Y.R., Stohler C.S., Nichols T.E., et al. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 26 (2006) 5777-5785
60. Walf A.A., and Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31 (2006) 1097-1111
61. Lund T.D., Rovis T., Chung W.C., and Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 146 (2005) 797-807
62. Chang L., Toner B.B., Fukudo S., et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 130 (2006) 1435-1446
63. Jamieson D.J., and Steege J.F. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 87 (1996) 55-58
64. Altman G., Cain K.C., Motzer S., et al. Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 29 (2006) 4-11
65. Whitehead W.E., Palsson O., and Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?. Gastroenterology 122 (2002) 1140-1156
66. Crowell M.D., Dubin N.H., Robinson J.C., et al. Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol 89 (1994) 1973-1977
67. Ahrendt H.J., Karckt U., Pichl T., et al. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eur J Contracept Reprod Health Care 12 (2007) 354-361
68. Brinkert W., Dimcevski G., Arendt-Nielsen L., et al. Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum. Pain 132 Suppl 1 (2007) S46-S51
69. Bajaj P., Bajaj P., Madsen H., and Arendt-Nielsen L. A comparison of modality-specific somatosensory changes during menstruation in dysmenorrheic and nondysmenorrheic women. Clin J Pain 18 (2002) 180-190
70. Winnard K.P., Dmitrieva N., and Berkley K.J. Cross-organ interactions between reproductive, gastrointestinal, and urinary tracts: Modulation by estrous stage and involvement of the hypogastric nerve. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1592-R1601
71. Pezzone M.A., Liang R., and Fraser M.O. A model of neural cross-talk and irritation in the pelvis: Implications for the overlap of chronic pelvic pain disorders. Gastroenterology 128 (2005) 1953-1964
72. Ustinova E.E., Fraser M.O., and Pezzone M.A. Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: An afferent origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol 290 (2006) F1478-F1487
73. Lea R., Bancroft K., and Whorwell P.J. Irritable bowel syndrome, chronic pelvic inflammatory disease and endometriosis: A comparison of symptomatology. Eur J Gastroenterol Hepatol 16 (2004) 1269-1272
74. Remorgida V., Ragni N., Ferrero S., et al. The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosis. Hum Reprod 20 (2005) 264-271
75. Ferrero S., Abbamonte L.H., Remorgida V., and Ragni N. Irritable bowel syndrome and endometriosis. Eur J Gastroenterol Hepatol 17 (2005) 687
76. Griffiths A.N., Koutsouridou R.N., and Penketh R.J. Predicting the presence of rectovaginal endometriosis from the clinical history: A retrospective observational study. J Obstet Gynaecol 27 (2007) 493-495
77. Yu J., Wang Y., Zhou W.H., et al. Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells. Hum Reprod 23 (2008) 1614-1626
78. Marshall J.K., Thabane M., Garg A.X., et al., for the Walkerton Health Study Investigators. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 131 (2006) 445-450 quiz 660
79. Dunlop S.P., Jenkins D., Neal K.R., and Spiller R.C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125 (2003) 1651-1659
80. Chadwick V.S., Chen W., Shu D., et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122 (2002) 1778-1783
81. Barbara G., Stanghellini V., De Giorgio R., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004) 693-702
82. Barbara G., Wang B., Stanghellini V., et al. Mast celldependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132 (2007) 26-37
83. Guilarte M., Santos J., de Torres I., et al. Diarrhoeapredominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 56 (2007) 203-209
84. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 28 (2007) 521-574
85. Alonso C., Guilarte M., Vicario M., et al. Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation [published correction appears in Gastroenterology. 2008;135:1017]. Gastroenterology 135 (2008) 163-172
86. Sherman J.J., and LeResche L. Does experimental pain response vary across the menstrual cycle? A methodological review. Am J Physiol Regul Integr Comp Physiol 291 (2006) R245-R256
87. Triadafilopoulos G., Finlayson M., and Grellet C. Bowel dysfunction in postmenopausal women. Women Health 27 (1998) 55-66
88. Cain KC, Jarrett ME, Burr RL, et al. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome [published online ahead of print November 1, 2008]. Dig Dis Sci.
89. Ruigómez A., García Rodríguez L.A., Johansson S., and Wallander M.A. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?. Maturitas 44 (2003) 133-140
90. Longstreth G.F., and Yao J.F. Irritable bowel syndrome and surgery: A multivariable analysis. Gastroenterology 126 (2004) 1665-1673
91. Kennedy T.M., and Jones R.H. The epidemiology of hysterectomy and irritable bowel syndrome in a UK population. Int J Clin Pract 54 (2000) 647-650
92. Feld A.D., Von Korff M., Levy R.L., et al. Excess surgery in irritable bowel syndrome (IBS). Gastroenterology 124 (2003) A388
93. Harlow S.D., Crawford S., Dennerstein L., et al., for the ReSTAGE Collaboration. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 10 (2007) 112-119
94. Greenspan J.D., Craft R.M., LeResche L., et al., for the Consensus Working Group of the Sex, Gender, and Pain SIG of the IASP. Studying sex and gender differences in pain and analgesia: A consensus report. Pain 132 Suppl 1 (2007) S26-S45